2cureX announced today the launch of the IndiTreat® mCRC Start test, to guide 1st line drug therapy in patients with metastatic colorectal cancer (mCRC). The test is the second in…
2cureX announced today the launch of the IndiTreat® mCRC Start test, to guide 1st line drug therapy in patients with metastatic colorectal cancer (mCRC). The test is the second in…